Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection
| Autor: | Mihaljevic-Peles, A., Sagud, M., Ivona Šimunović Filipčić, Grosic, V., Pedisic, I., Emsley, R. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Adult
Employment Male Psychiatric Status Rating Scales schizophrenia risperidone long-acting injectable (RLAI) non-adherence remission employment in schizophrenia Croatia Rehabilitation Vocational Middle Aged Risperidone Injections Intramuscular Treatment Outcome Pregnancy Delayed-Action Preparations Schizophrenia Humans Female Schizophrenic Psychology Prospective Studies |
| Zdroj: | Psychiatria Danubina Volume 28 Issue 3 Scopus-Elsevier |
| ISSN: | 0353-5053 |
| Popis: | Background: While numerous studies have confirmed the efficacy of risperidone long-acting injectable (RLAI) on many clinical outcomes in patients with schizophrenia, there is no data regarding its influence on employment status. Subject and methods: This was a 12-month observational study with flexible doses of RLAI on a Croatian population of patients with schizophrenia and other psychoses. Visits were at baseline and after 1, 3, 6 and 12 months of treatment. Treatment response was evaluated using Clinical Global Impression of Illness Severity (CGI-S) and Improvement (CGI-I) scales, while remission was defined by 8 items of Positive and Negative Syndrome Scale (PANSS). Employment status was determined at baseline and at study endpoint. Results: A total of 362 patients were included, with a median age of 37 (interquartile range 29- 47) years, 63.5 % were males and 67.4% were hospitalised at baseline. Overall 258 (71.3%) patients completed the study. Improvements in CGI-S scores from baseline were significant (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|